Speakers
  • home
  • Program
  • Speakers

Keynote Speakers

  • cv
    Keynote 1 Sunghoon Kim Seoul National University
    Korea
    Uncovering Novel Biomarkers for Next Generation Theranostics
  • cv
    Keynote 2 Michael Hofman Peter MacCallum Cancer Centre
    Australia
    Practical Applications and Future Prospects of Radiotheranostics
  • cv
    Keynote 3 Hans-Jürgen Wester Technical University of Munich
    Germany
    Radiohybrids: A Groundbreaking New Theranostics Tracer Concept
  • cv
    Keynote 5 Richard Baum Central Clinic Bad Berka
    Germany
    Personalized Cancer Therapy: From Innovation to Implementation using Theranostics and Precision Oncology
  • cv
    Keynote 6 Dong Soo Lee Seoul National University
    Korea
    Brain Theranostics

[Opening Ceremony] & [Closing Remarks]

  • cv
    Min-Koo Han KAST
    Korea
  • cv
    Myung Chul Lee KAST
    Korea
  • cv
    Horacio Amaral PositronMed
    Chile
  • cv
    Vasko Kramer PositronPharma
    Chile

[Scientific Session 1] Current Status of Theranostics

  • cv
    Kambiz Rahbar University Hospital Münster (UKM)
    Germany
    Clinical Experiences with PSMA-1007: Current Status
  • cv
    Markus Essler University Hospital Bonn
    Germany
    Clinical Experieces of Lu-177 PSMA Combined or for Other Cancers
  • cv
    Wolfgang Weber Technical University of Munich
    Germany
    Future Perspectives of Theranostics in Germany
  • cv
    Richard Wahl Washington University
    USA
    Future Perspectives of Theranostics in USA

[Scientific Session 2] Theranostics of Prostate Cancer

  • cv
    Cheol Kwak Seoul National University
    Korea
    Unmet Clinical Needs in Advanced Prostate Cancer
  • cv
    Yang-sook Chun Seoul National University
    Korea
    New Therapeutic Target
  • cv
    Yun-Sang Lee Seoul National University
    Korea
    Simplest Glu-Urea-Lys (EUK) for PSMA
  • cv
    Dae Yoon Chi Sogang University
    Korea
    Theranostic Agents for Targeting PSMA: Development of F-18 and Alpha Emitters

[Reports 1] Current Status of Asia

  • cv
    Keon Wook Kang Seoul National University
    Korea
    Theranostics in Korea
  • cv
    Seigo Kinuya Kanazawa University
    Japan
    Theranostics in Japan
  • cv
    Feng Wang Nanjing Medical University
    China
    Theranostics in China

[Scientific Session 3-1] Next Generation Theranostics (from Chemists' Point of View) - Novel Targets and Probes

  • cv
    Frank Rösch Institute of Nuclear Chemistry University Mainz
    Germany
    Instant Kit-type Labelling Chemistry for 68Ga, 44Sc, 177Lu.
  • cv
    Henry VanBrocklin The University of California, San Francisco (UCSF)
    USA
    Image Guided Therapy: Development of Oncologic and Non-oncologic Agents
  • cv
    Yuji Kuge Hokkaido University
    Japan
    Potential Use of Hypoxia and Thymidine Phosphorylase Imaging Probes for Theranostics
  • cv
    Klaus Kopka German Cancer Research Center
    Germany
    The Heidelberg Series of Glu-ureido based PSMA Tracers: Adaption of Chemical Structure to Clinical Indication
  • cv
    Jae Min Jeong Seoul National University
    Korea
    Imaging of the Third Gasotransmitter

[Scientific Session 3-2] Next Generation Theranostics (from Chemists' Point of View) - Alpha Emitters

  • cv
    Cathy Cutler Brookhaven National Laboratory
    USA
    Alpha-emitters
  • cv
    Michael K. Schultz University of Iowa Carver College of Medicine
    USA
    Pb-203/Pb212 Peptide Receptor Targeted Theranostics for Cancer
  • cv
    Michael Zalutsky Duke University School of Medicine
    USA
    Nanobodies: A Promising Platform for Theranostics Development

[Reports 2] Global Practical Progress

  • cv
    Mike Sathekge University of Pretoria
    South Africa
    Implementation of Novel Theranostics in Africa
  • cv
    Patricia Bernal Trujillo Universidad Javeriana
    Colombia
    Struggles of Theranostics in Latin America
  • cv
    Carlos Buchpiguel University of São Paulo
    Brazil
    Theranostics in Brazil
  • cv
    Fani Bozkurt Hacettepe University
    Turkey
    Theranostics Efforts between Europe and Asia
  • cv
    Partha Choudhury Hacettepe University
    India
    Optimization of Novel Radionuclide Therapies in India

[Scientific Session 4] Next Generation Theranostics (from Physicists' Point of View)

  • cv
    Mark Konijnenberg Erasmus Medical Center
    The Netherlands
    Prospective Dosimetry Options for Alpha-emitter Targeted Therapy
  • cv
    Jae Sung Lee Seoul National University
    Korea
    New Approaches to Fast Voxel-based Dosimetry
  • cv
    Greta Seng Peng Mok University of Macau
    Macau
    3D Voxel Dosimetry
  • cv
    Makoto Hosono Kindai University
    Japan
    ICRP Perspectives for Individualized Radionuclide Therapy

[TEIN Luncheon Seminar] TEIN Luncheon Seminar

  • cv
    Lingeswaran Kasilingam Beacon Hospital
    Malaysia
  • cv
    Hendra Budiawan Hasan Sadikin Hospital, Bandung
    Indonesia
  • cv
    Pham Cam Phuong Bach Mai Hospital
    Vietnam
  • cv
    Shamim Momtaz Ferdousi Begum National Institute of Nuclear Medicine & Allied Sciences
    Bangladesh

[Scientific Session 5-1] Next Generation Theranostics (from Convergents' Point of View)

  • cv
    Anna Wu University of California Los Angeles
    USA
    Antibody Theranostics
  • cv
    Young Kee Shin Seoul National University
    Korea
    In Vitro to in Vivo Companion Diagnostics
  • cv
    Jung-Joon Min Chonnam National University
    Korea
    Bacteria-based Radio-theranostics
  • cv
    Andrei Iagaru Stanford University
    USA
    Gastrin-Releasing Peptide Receptors for Theranostics in Prostate Cancer

[Scientific Session 5-2] Next Generation Theranostics (from Physicians' Point of View)

  • cv
    Michael Kreissl University Hospital Magdeburg
    Germany
    Theranostics in Combination with Local Therapies
  • cv
    Matthias Eiber Technical University of Munich
    Germany
    PSMA Targeting Alpha Therapies
  • cv
    Steve Cho University of Wisconsin School of Medicine and Public Health
    USA
    Porposed Criteria Positions PSMA for the Future

[Reports 3] Standpoints of Patient Advocates

  • cv
    Josh Mailman NorCal CarciNet Community
    USA
    USA Experiences
  • cv
    Song-hoon Ham
    Korea
    Korean Experiences
  • cv
    Yoshiyuki Majima NPO PanCAN
    Japan
    Japanese Experiences

[Scientific Session 5-3] Next Generation Theranostics (from Innovators' Point of View)

  • cv
    Beat Loeffler CLINAM - European Foundation for Clinical Nanomedicine
    Switzerland
    Nanomedicine: 11 Years of European Efforts
  • cv
    Dong Soo Lee Seoul National University
    Korea
    Introduction to Radionanomedicine
  • cv
    Weibo Cai University of Wisconsin–Madison
    USA
    Radiolabeled Nanomaterials: Ready for Clinical Translation
  • cv
    Seung-Hoon Lee Seoul National University
    Korea
    Therapeutic Nanoparticles awaiting for Theranostic Use
Organized by
Supported by
Gold
Silver